FOUR CYCLES OF R-CHOP SHOW THE SAME EFFECTIVITY AS SIX CYCLES IN REAL-WORLD DLBCL PATIENTS WITH LOCALIZED, NON-BULKY DISEASE INDEPENDENTLY OF OTHER UNFAVOURABLE RISK FACTORS

EHA Library, Diana Malarikova, 4161010

ORELABRUTINIB, RITUXIMAB, AND THIOTEPA (ORT) IN COMBINATION WITH ORWITHOUT HIGH-DOSE METHOTREXATE IN UNTREATED PRIMARY CENTRAL NERVOUSSYSTEM LYMPHOMA

EHA Library, Wenjuan Yu, 4161013

PATIENT PREFERENCES FOR ATTRIBUTES OF BISPECIFIC ANTIBODIES INDICATED FOR THE TREATMENT OF RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA IN THE UNITED STATES

EHA Library, Erin Mulvey, 4161018

BRUTON'S TYROSINE KINASE (BTK) INHIBITORS FOR THE FIRST-LINE TREATMENT OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL): A RETROSPECTIVE SINGLE CENTER STUDY

EHA Library, Fang shu Guan, 4161019

PREEMPTIVE TMP-SMX/N-ACETYLCYSTEINE PROPHYLAXIS MITIGATES THE INCIDENCE OF INTERSTITIAL PNEUMONIA IN DLBCL IMMUNOCHEMOTHERAPY: A DUAL-CENTER COHORT STUDY ON RISK STRATIFICATION AND CLINICAL OUTCOMES

EHA Library, wenwen wang, 4161020

RAPID RAMP-UP OF BI-SPECIFIC ANTIBODIES IN RELAPSED OR REFRACTORY LARGE B-CELL LYMPHOMA

EHA Library, Yucai Wang, 4161023

NOVEL SMALL MOLECULAR TARGET AGENTS WITH HD-MTX-BASED REGIMENS IMPROVED REMISSION RATES WITHOUT PROLONGING PFS IN NEWLY DIAGNOSED PCNSL

EHA Library, Huiying Zhu, 4161024

EXPLORING DISPARITIES IN SURVIVAL OUTCOMES OF PRIMARY CARDIAC DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): A SEER DATABASE ANALYSIS

EHA Library, Jeyapradeeban Arunachalam, 4161025

COMPARATIVE EFFICACY OF THERAPEUTIC APPROACHES IN RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS

EHA Library, Abat Khan, 4161026

COMPARISON OF 18F-FDG PET/CT AND BONE MARROW BIOPSY IN DETECTION OF BONE MARROW INVOLVEMENT IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Fahong Yan, 4161033

GLOFITAMAB COMBINED WITH SALVAGE THERAPY FOR RELAPSED OR REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA: A REAL-WORLD PROSPECTIVE OBSERVATIONAL STUDY IN CHINESE PATIENTS

EHA Library, Haiwen Huang, 4161037

PEGFILGRASTIM VS. FILGRASTIM FOR FEBRILE NEUTROPENIA PREVENTION IN THE FIRST CYCLE OF POLATUZUMAB VEDOTIN-R-CHP (POLA-R-CHP): A NATIONWIDE COHORT STUDY IN NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Nobuyuki Kabasawa, 4161039

EXPOSURE TO PM10 ELEVATES THE RISK OF DIFFUSE LARGE B-CELL LYMPHOMA: A PROSPECTIVE STUDY IN THE UK BIOBANK COHORT

EHA Library, Yiyin Chen, 4161040

COMBINATION OF LIPOSOMAL MITOXANTRONE WITH CYCLOPHOSPHAMIDE, VINCRISTINE, AND PREDNISONE (CMOP) IN TREATMENT-NAÏVE PERIPHERAL T-CELL LYMPHOMA: A MULTICENTER, OPEN-LABEL, SINGLE-ARM, PHASE IB STUDY

EHA Library, Huiqiang Huang, 4161045

CHIDAMIDE IN COMBINATION WITH AZACITIDINE, MITOXANTRONE LIPOSOMES, AND PREDNISONE (CAMP REGIMEN) FOR TREATMENT-NAÏVE TFH-DERIVED PERIPHERAL T-CELL LYMPHOMA

EHA Library, Huimin Liu, 4161049

SUBDIAPHRAGMATIC DISEASE AND HIGH FIL SCORE PERFORM BETTER THAN IPI IN IDENTIFYING A SUBGROUP OF PATIENTS WITH PRIMARY MEDIASTINAL B-CELL LYMPHOMA WITH A LESS FAVOURABLE PROGNOSIS

EHA Library, Simone Maifredi, 4161052

EPCORITAMAB WITH GEMCITABINE, DEXAMETHASONE, AND CISPLATIN (EPCO-GDP) IN RELAPSED REFRACTORY LARGE B-CELL LYMPHOMA- AN INTERIM ANALYSIS OF PHASE II MULTICENTER INVESTIGATED-INITIATED TRIAL

EHA Library, Dipenkumar Modi, 4161053

LONG-TERM FOLLOW-UP REVEALS CURATIVE POTETIAL AND FAVORABLE SAFETY OF CD19/22 CAR-T THERAPY, ALONE OR IN COMBINATION WITH ASCT, IN TP53-ALTERED RELAPSED/REFRACTORY B-NHL

EHA Library, Juan Peng, 4161056

DLBCL-ASSOCIATED PIM1 MUTATION DRIVES ANXA2 RELOCATION ON THE MEMBRANE AND PROMOTES LYMPHOMAGENESIS

EHA Library, Yaxiao Lu, 4161057

NR4A1 LOSS PROMOTES AN IMMUNOSUPPRESSIVE TUMOR MICROENVIRONMENT AND ENHANCES LYMPHOMA PROGRESSION

EHA Library, Katrin Pansy, 4161059

DC-SIGN LOCALIZATION AND CONTRIBUTION TO TUMOUR CELL FUNCTION IN FOLLICULAR LYMPHOMA

EHA Library, Giorgia Chiodin, 4161060

CD4+ CADM1+ T CELL POPULATION EMERGES AS A MALIGNANCY-ASSOCIATED BIOMARKER IN EBV-RELATED LYMPHOPROLIFERATIVE DISORDERS

EHA Library, Qinhuan Luo, 4161062

PROTEOMIC PROFILING USING HIGH-DIMENSIONAL MULTIPLEX PLATFORMS TO IDENTIFY PROSPECTIVE RISK FACTORS FOR LYMPHOID MALIGNANCIES ACROSS MULTIPLE COHORTS

EHA Library, Pieter Martijn Kolijn, 4161064

ASSESSMENT OF CIRCULATING TUMOR DNA (CTDNA) FOR RESPONSE PREDICTION AND GENETIC CHARACTERIZATION OF RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA (R/R LBCL) RECEIVING GLOFITAMAB TREATMENT

EHA Library, Chiara Signori, 4161065

EMBRYONIC ECTODERM DEVELOPMENT (EED) INHIBITOR APG-5918 EXHIBITS POTENT ANTITUMOR ACTIVITY AND SYNERGIZES WITH HISTONE DEACETYLASE INHIBITOR TUCIDINOSTAT IN PRECLINICAL T-CELL LYMPHOMA (TCL) MODELS

EHA Library, Eric Liang, 4161067

A GENOME-WIDE CRISPR SCREEN IDENTIFIES UBE2A LOSS-OF-FUNCTION TO CONFER BORTEZOMIB SENSITIVITY IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Hanne DUE, 4161068

ADVANTIG-101: A PHASE 1B/2 STUDY OF OCIPERLIMAB (ANTI-TIGIT) PLUS TISLELIZUMAB (ANTI-PD-1) OR RITUXIMAB IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Yuqin Song, 4161069

RACIAL AND CLINICAL DETERMINANTS OF RESPONSE IN 2,304 RELAPSE/REFRACTORY B-CELL LYMPHOMAS TREATED WITH ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR T-CELL IN CLINICAL TRIALS

EHA Library, Soon Jye Kho, 4161070

COMPREHENSIVE ANALYSIS OF MUTATIONAL SIGNATURES IN PATIENTS WITH RELAPSED/REFRACTORY LBCL BY CIRCULATING TUMOR DNA SEQUENCING

EHA Library, Sophie Heidenreich, 4161072

UNLOCKING THE POTENTIAL OF EXTRACELLULAR VESICLES: PREDICTIVE BIOMARKERS FOR IMMUNE HYPERACTIVITY AND ENDOTHELIAL DAMAGE FOLLOWING CAR-T CELLS.

EHA Library, Michele Dicataldo, 4161074

PREDICTIVE VALUE OF CTDNA AND MRD DYNAMICS IN DIFFUSE LARGE B-CELL LYMPHOMA: A PROSPECTIVE COHORT STUDY

EHA Library, Xiao Liu, 4161077

ANTITUMOR CHARACTERIZATION OF IPH6501, A NOVEL IL2V-ARMED TETRASPECIFIC NK CELL ENGAGER TARGETING CD20 B CELLS, IN DLBCL AND FL PATIENT SAMPLES, AND IN PRECLINICAL COMBINATION WITH R-CHOP

EHA Library, Florent Carrette, 4161078

GENOMIC TESTING IN PATIENTS WITH LARGE CELL AND FOLLICULAR LYMPHOMA TREATED WITH T-CELL ENGAGERS BI-SPECIFIC ANTIBODIES AND CORRELATION WITH TREATMENT RESPONSE

EHA Library, Rita Tavarozzi, 4161081

IMPACT OF LARGE B-CELL LYMPHOMA (LBCL) GENOMICS ON CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) TREATMENT OUTCOMES

EHA Library, Marc Bosch Schips, 4161083

SYSTEMS BIOLOGY-ENABLED TARGETING OF NF-κB AND BCL2 OVERCOMES MICROENVIRONMENT-MEDIATED BH3-MIMETIC RESISTANCE IN DLBCL

EHA Library, Aimilia VARELI, 4161085

THE ONCOGENIC FYN::TRAF3IP2 FUSION SHAPES THE TUMOR MICROENVIRONMENT IN PTCL-NOS

EHA Library, Yilke Schoenmaekers, 4161086

ABERRANT EXPRESSION AND ONCOGENIC ACTIVITY OF SPP1 IN HODGKIN LYMPHOMA

EHA Library, Nagel Stefan, 4161087

NOVEL IMMUNOPHENOTYPIC APPROACHES TO IMPROVE THE DIAGNOSTIC CLASSIFICATION OF MATURE T-CELL NEOPLASMS

EHA Library, Alberto Orfao, 4161088

A STUDY ON THE MECHANISM OF ACTION OF THE NOVEL HIGHLY SELECTIVE HDAC INHIBITOR PURINOSTAT MESYLATE IN DOUBLE-HIT LYMPHOMA AND ITS THERAPEUTIC POTENTIAL IN COMBINATION WITH VENETOCLAX

EHA Library, Jie Wang, 4161093

TO EXPLORE THE EFFECT AND MECHANISM OF ZANUBRUTINIB, LENALIDOMIDE, TEMOZOLOMIDE IN THE TREATMENT OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA

EHA Library, Rong Fu, 4161094

THE SIGNIFICANCE OF HLA PHYLOGENETICALLY RELATED COUNTRIES IN THE CREATION OF IPSC HAPLOBANKS AGAINST THE REGIONAL HLA HETEROGENEITY.

EHA Library, Helen Papadaki, 4161097

BONE MARROW SELENOP+ MACROPHAGES PROMOTE HEMATOPOIETIC RECONSTITUTION AFTER TRANSPLANTATION VIA GAS6-AXL SIGNALING PATHWAY

EHA Library, Mengzhu Shen, 4161098

GENETIC POLYMORPHISMS OF ENZYMES METABOLIZING CYCLOPHOSPHAMIDE IS ASSOCIATED WITH THE CLINICAL OUTCOMES OF HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Huai-Chueh Gem Wu, 4161099

STEARIC ACID-INDUCED MACROPHAGE PYROPTOSIS EXACERBATES THE SEVERITY OF AGVHD

EHA Library, Xue-Yan Sun, 4161100

A RANDOMIZED TRIAL OF THREE GVHD PROPHYLAXIS REGIMENS IN HAPLOIDENTICAL PERIPHERAL BLOOD STEM CELL TRANSPLANT: ANTITHYMOCYTE GLOBULIN, POSTTRANSPLANT CYCLOPHOSPHAMIDE, AND LOW-DOSE COMBINATION THERAPY

EHA Library, Yannan Jia, 4161101

DYNAMIC IMMUNE RECONSTITUTION AND CLINICAL OUTCOMES OF THREE DIFFERENT PROTOCOLS FOR HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Xiao-Di Ma, 4161102

THE EFFECTS OF PRIOR LINES OF THERAPY ON CLINICAL OUTCOMES FOR PATIENTS WITH CHRONIC GRAFT-VERSUS-HOST DISEASE RECEIVING AXATILIMAB: A POST HOC ANALYSIS OF AGAVE-201

EHA Library, Valkal Bhatt, 4161103

MAAT033 TO ENSURE OPTIMAL GUT MICROBIOTA TO IMPROVE SURVIVAL IN PATIENTS? RECEIVING ALLOGENEIC HCT: PHOEBUS TRIAL

EHA Library, Natalia Gemperle Ortiz, 4161105

SELECTIVE ASO-BASED JAK2 INHIBITOR FOR THE TREATMENT OF HEMATOLOGICAL MALIGNANCIES WITH JAK2 V617F MUTATION BURDEN

EHA Library, Sandra Smieszek, 4160678

BRENTUXIMAB VEDOTIN (BV) IN RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMAS (R/R PTCL): A MULTICENTER RETROSPECTIVE STUDY

EHA Library, Ivan Dlouhy, 4161009

MAINTENANCE THERAPY OF GOLIDOCITINIB, A JAK1 SELECTIVE INHIBITOR, IN PATIENTS WITH PERIPHERAL T CELL LYMPHOMAS AFTER FIRST-LINE SYSTEMIC THERAPY: UPDATES OF THE PHASE 2 STUDY (JACKPOT26)

EHA Library, Jie Jin, 4161011

INFECTIOUS COMPLICATIONS OF AGENTS USED IN T-CELL LYMPHOMAS: A DISPROPORTIONALITY ANALYSIS USING THE FAERS DATABASE

EHA Library, Toshali Pandey, 4161012

TREATMENT AND OUTCOMES OF NEWLY DIAGNOSED PRIMARY MEDIASTINAL B-CELL LYMPHOMA: A PORTUGUESE POPULATION-BASED STUDY

EHA Library, Maria Carolina AFONSO, 4161014

LINPERLISIB COMBINED WITH CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANTATION AND LINPERLISIB MAINTENANCE IN PATIENTS WITH NEWLY DIAGNOSED NODAL T FOLLICULAR HELPER CELL LYMPHOMA: INTERIM ANALYSIS OF A PHASE II TRIAL

EHA Library, Weiping Liu, 4161015

MATCH-ADJUSTED COMPARATIVE ANALYSIS OF THE EFFICACY OF EPCORITAMAB + R-MINICHOP VS R-MINICHOP IN PREVIOUSLY UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Justin Darrah, 4161016

ORELABRUTINIB ADDITION TO R-CHOP-LIKE REGIMEN ADAPTED TO RESPONSE IN TREATMENT-NAÏVE NON-GCB DLBCL: UPDATE RESULTS OF ORIENT STUDY

EHA Library, Chang-Ju Qu, 4161017

EFFECTIVENESS AND GENE PROFILE OF FRONT-LINE POLA-BASED REGIMEN FOR DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): A REAL-WORLD, SINGLE-CENTER STUDY INCLUDING DATA ON TP53 MUTATED PATIENTS

EHA Library, Jia Liu, 4161021

PERSISTING THROMBOCYTOPENIA AFTER CD19-DIRECTED CAR-T CELL THERAPY IS A PREDICTOR OF WORSE SURVIVAL IN RELAPSED / REFRACTORY LBCL PATIENTS

EHA Library, Akhil Behringer, 4161022

PROGNOSTIC VALUE OF EZH2-POSITIVE TUMOR CELLS AND CD8 T-LYMPHOCYTES OF THE MICROENVIRONMENT IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Vitaliy Rosin, 4161027

LATEST UPDATE RESULTS OF P-GEMD REGIMEN IN NEWLY DIAGNOSED EARLY NON-UPPER AERO-DIGESTIVE TRACT OR ADVANCED STAGE EXTRANODAL NK/T CELL LYMPHOMA

EHA Library, Jinhua Liang, 4161028

DIAGNOSTIC DISCREPANCY OF CT AND FDG PET-CT AT INTERIM STAGING AND END OF TREATMENT IN FRAIL PATIENTS WITH LBCL TREATED WITH R-MINICHOP+/-ACALABRUTINIB

EHA Library, Igor Age Kos, 4161029

INTERIM ANALYSIS OF POMALIDOMIDE PLUS RITUXIMAB, IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE (PR-ICE) IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A PHASE I/II STUDY (PRIDE STUDY)

EHA Library, WeiLi Zhao, 4161030

UPDATED SAFETY RUN-IN RESULTS FROM LOTIS-5: A PHASE 3, RANDOMIZED TRIAL OF LONCASTUXIMAB TESIRINE WITH RITUXIMAB VERSUS IMMUNOCHEMOTHERAPY IN PATIENTS WITH R/R DLBCL/HGBL

EHA Library, Carmelo Carlo-Stella, 4161031

THE EFFECT OF KIR HAPLOTYPE ON CLINICAL COURSE IN PATIENTS WITH METHOTREXATE-ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS

EHA Library, Norina Tanaka, 4161032

A COMBINED EASIX-IPI (E-IPI) SCORE IMPROVES THE PROGNOSTIC STRATIFICATION OF NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

EHA Library, Jing Yuan Tan, 4161034

CLADRIBINE AND VENETOCLAX FOR TREATMENT OF PATIENTS WITH RELAPSED AND REFRACTORY T-CELL PROLYMPHOCYTIC LEUKEMIA

EHA Library, Caitlin Rausch, 4161035

PREDICTIVE FACTORS OF FAILURE OF CAR T CELLS AS A SECOND-LINE THERAPY FOR REFRACTORY OR EARLY-RELAPSING LARGE B-CELL LYMPHOMA

EHA Library, Agathe Vély, 4161036

CLINICAL FEATURES AND OUTCOMES OF EXTRANODAL NK/T-CELL LYMPHOMA INCLUDING EXTRANASAL DISEASE

EHA Library, Yuka Morita, 4161038

EFFECTIVENESS AND SAFETY OF POLA-R-CHP REGIMEN IN PREVIOUSLY UNTREATED LOW-RISK DLBCL: A NATIONWIDE MULTICENTER RETROSPECTIVE STUDY OF IPI 0-1 PATIENTS IN CHINA

EHA Library, Yuhong Ren, 4161041

ORELABRUTINIB PLUS BENDAMUSTINE-RITUXIMAB (OBR) VERSUS BENDAMUSTINE-RITUXIMAB (BR) IN TRANSPLANT-INELIGIBLE, INTERMEDIATE- TO HIGH-RISK MANTLE CELL LYMPHOMA (MCL)

EHA Library, Li Wang, 4161043

MAINTAINING R-CHOP INTENSITY IS ASSOCIATED WITH PROLONGED DURATION OF COMPLETE REMISSION IN LARGE B-CELL LYMPHOMA: A MULTI-CENTER REAL-LIFE DATA OF 953 PATIENTS FROM TÜRKIYE

EHA Library, Umut Yılmaz, 4161044

ORELABRUTINIB COMBINED WITH ICE REGIMEN WITH OR WITHOUT RITUXIMAB (O-ICE±R) FOR RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA WITH EXTRANODAL INVOLVEMENT

EHA Library, Xianggui Yuan, 4161046

EFFICACY OF BTK INHIBITOR, RITUXIMAB, AND LENALIDOMIDE COMBINATION THERAPY IN NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA: A SINGLE-CENTER RETROSPECTIVE ANALYSIS IN CHINA

EHA Library, Yunfei Lv, 4161047

CD47 IMMUNOEXPRESSION DOES NOT CORRELATE WITH RESPONSE TO IMMUNOCHEMOTHERAPY AND OUTCOME IN PATIENTS WITH LARGE B-CELL LYMPHOMA

EHA Library, Ilija Bukurecki, 4161048

CLINICAL OUTCOMES OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH HEPATOSPLENIC T-CELL LYMPHOMA

EHA Library, Zhuoxin Zhang, 4161050

ASSOCIATION OF DYNAMIC CHANGES IN METABOLIC SYNDROME COMPONENTS WITH CLINICAL OUTCOMES IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Dewan Zhao, 4161051

ADVANCING PROGNOSIS: A ROBUST PREDICTIVE MODEL FOR LONG-TERM SURVIVAL IN R/R LBCL PATIENTS TREATED WITH CD19 CAR-T THERAPY

EHA Library, Hu Qian, 4161054

DISSECTING THE HELLS GENE SIGNATURE IN ANAPLASTIC LARGE CELL LYMPHOMA: IMPLICATIONS FOR DRUG REPURPOSING AND COMBINATION THERAPY

EHA Library, Valentina Fragliasso, 4161055

NON-VIRAL CD79B-TARGETED CARCIK CELLS ARMORED WITH IL-18: GOING BEYOND CD19 TARGETING

EHA Library, Beatrice Landoni, 4161058

LONG NONCODING RNA MTAAT REGULATES PD-L1 SUBCELLULAR TRAFFICKING IN T-CELL LYMPHOMA THROUGH ARF6

EHA Library, Selene Mallia, 4161061

CLONAL HEMATOPOIESIS IN FOLLICULAR LYMPHOMA: ANALYSIS OF THE PHASE III FIL FOLL12 TRIAL

EHA Library, Riccardo Moia, 4161063

TARGETING MICRORNAS TO OVERCOME DRUG RESISTANCE IN DIFFUSE LARGE B-CELL LYMPHOMA: A FUNCTIONAL AND CLINICAL STUDY FOR THE DEVELOPMENT OF RNA-BASED COMPLEMENTARY THERAPIES.

EHA Library, Giulia Regazzo, 4161066

DISTINCT T-CELL PROFILES AND INSIGHTS INTO T-CELL RESPONSES IN SPLENIC SMALL B-CELL MALIGNANCIES

EHA Library, Elisavet Vlachonikola, 4161071

TRANSLATIONAL FINDINGS FROM THE PHASE 2 LUMINICE-203 STUDY OF ACIMTAMIG (AFM13) IN COMBINATION WITH ALLONK® (AB-101) IN PATIENTS WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA (R/R CHL)

EHA Library, Joseph Maakaron, 4161073

PEMBROLIZUMAB THERAPY INDUCES AN INFLAMMATORY RESPONSE IN LYMPHOMA PATIENTS BY RESHAPING MONOCYTES RESULTING IN HYPERPROGRESSIVE DISEASE

EHA Library, Zhi-Zhang Yang, 4161075

ENDOCYTIC MODULATION UNVEILS A NOVEL MECHANISM OF NOTCH1 ACTIVATION IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Paolo Sportoletti, 4161076

LCP2 MEDIATES SUV39H1-DRIVEN CELLULAR SENESCENCE-RELATED CHEMORESISTANCE IN NATURAL KILLER/T CELL LYMPHOMA

EHA Library, Yue Zhang, 4161079

EXPERT-INDEPENDENT CLASSIFICATION OF T-CELL CHRONIC LYMPHOPROLIPHERATIVE DISORDERS USING STANDARDIZED FLOW CYTOMETRY

EHA Library, Sonia Carretero-Domínguez, 4161080

A DELICATE BALANCE BETWEEN EPSTEIN-BARR VIRUS (EBV) INDUCED MUTAGENESIS AND DNA REPAIR DICTATES STABILIZED LATENCY OR LYTIC POTENTIATION: IMPLICATIONS FOR EBV ASSOCIATED LYMPHOMAGENESIS

EHA Library, Tom Howard, 4161082

THE NOVEL ENHANCER-DERIVED LNCRNA U47924.31 SENSITIZES TO R-CHOP IMMUNO-CHEMOTHERAPY SERVING AS A NEW POTENTIAL THERAPEUTIC TARGET IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Giulia Vari, 4161084

COMPREHENSIVE EVALUATION OF OTHER IATROGENIC IMMUNODEFICIENCY-ASSOCIATED LYMPHOPROLIFERATIVE DISEASE ELUCIDATES THE UNIQUE IMPACT OF METHOTREXATE-BASED IMMUNOSUPPRESSION AND EBV INFECTION

EHA Library, Yuki Furukawa, 4161089

PRE-INFUSION CD57+ CAR-T CELL FREQUENCY AND EARLY POST-INFUSION PD-1 EXPRESSION CORRELATE WITH CLINICAL OUTCOMES FOLLOWING CAR-T CELL THERAPY FOR HEMATOLOGICAL MALIGNANCIES

EHA Library, yajing zhang, 4161090

DETECTION OF CHROMOSOMAL REARRANGEMENTS IN PEDIATRIC T-LYMPHOBLASTIC LYMPHOMA USING HI-C-SEQUENCING

EHA Library, Vlada Tuliavko, 4161091

DEVELOPMENT OF PATIENT-DERIVED 3D LYMPHOMA CULTURE MODELS FOR PERSONALIZAED TREATMENT EVALUATION

EHA Library, Ana Belén Arroyo-Rodríguez, 4161092

POLYMORPHONUCLEAR MYELOID-DERIVED SUPPRESSOR CELLS REPROGRAM FATTY ACID METABOLISM TO INDUCE IMMUNOSUPPRESSION IN PATIENTS RECEIVING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Yujun Wei, 4161095

PREVALENCE AND ORIGINS OF CLONAL HEMATOPOIESIS IN LONG-TERM SURVIVORS OF PEDIATRIC HEMATOPOIETIC CELL TRANSPLANTATION

EHA Library, Mirjam Belderbos, 4161096

DROPLET DIGITAL PCR FOR MRD MONITORING STANDS AS A PROMISING APPROACH IN PREDICTING RELAPSE AT THE EARLIEST FOR PATIENTS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Xiao Zhou, 4161104

CHIDAMIDE MONOTHERAPY PREVENTS THE RELAPSE OF HIGH-RISK MYELOID MALIGNANCIES POST-ALLO-HSCT: A PROSPECTIVE, SINGLE-CENTER, PHASE I/II TRIAL

EHA Library, Qiushi Liang, 4161106

RANDOMIZED TRIAL OF ANTI-THYMOCYTE GLOBULIN PLUS LOW-DOSE POSTTRANSPLANT CYCLOPHOSPHAMIDE FOR GVHD PREVENTION IN HAPLOIDENTICAL TRANSPLANTATION

EHA Library, Yu Wang, 4161107

UNMET NEEDS IN CHRONIC GRAFT-VERSUS-HOST DISEASE MANAGEMENT: FRENCH SUBSET ANALYSIS OF EUROPEAN PATIENTS WHO PREVIOUSLY RECEIVED 2 TO 5 LINES OF THERAPY

EHA Library, Darko Kiprijanovski, 4161108